NRX Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $13.0M
Liabilities Breakdown FY2025
Total Liabilities: $28.9M
Asset Breakdown
Total Assets: $13.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $7.8M | 60.2% |
| Accounts Receivable | $161.0K | 1.2% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $63.0K | 0.5% |
| Goodwill | $1.8M | 13.8% |
| Intangible Assets | $925.0K | 7.1% |
| Other Assets | $2.2M | 17.1% |
Liabilities Breakdown
Total Liabilities: $28.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.3M | 14.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $24.6M | 85.2% |